nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlodipine—CYP1A1—Clobetasol propionate—psoriasis	0.0733	0.103	CbGbCtD
Amlodipine—CYP2A6—Methoxsalen—psoriasis	0.045	0.0635	CbGbCtD
Amlodipine—CYP1A1—Methoxsalen—psoriasis	0.0385	0.0543	CbGbCtD
Amlodipine—CYP2C8—Tazarotene—psoriasis	0.0345	0.0486	CbGbCtD
Amlodipine—CYP3A5—Beclomethasone—psoriasis	0.0333	0.047	CbGbCtD
Amlodipine—CYP1A2—Clobetasol propionate—psoriasis	0.0327	0.0461	CbGbCtD
Amlodipine—CYP1A1—Cholecalciferol—psoriasis	0.0255	0.0359	CbGbCtD
Amlodipine—CYP2A6—Prednisolone—psoriasis	0.0219	0.0309	CbGbCtD
Amlodipine—CYP2B6—Cholecalciferol—psoriasis	0.0194	0.0274	CbGbCtD
Amlodipine—CYP1A2—Methoxsalen—psoriasis	0.0172	0.0242	CbGbCtD
Amlodipine—CACNA1S—pes—psoriasis	0.017	0.65	CbGeAlD
Amlodipine—CYP2D6—Hydroxyurea—psoriasis	0.0155	0.0218	CbGbCtD
Amlodipine—CYP2C8—Cholecalciferol—psoriasis	0.0147	0.0207	CbGbCtD
Amlodipine—CYP3A7—Hydrocortisone—psoriasis	0.0142	0.02	CbGbCtD
Amlodipine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0142	0.02	CbGbCtD
Amlodipine—CYP3A7—Cyclosporine—psoriasis	0.0134	0.0189	CbGbCtD
Amlodipine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0134	0.0189	CbGbCtD
Amlodipine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0133	0.0187	CbGbCtD
Amlodipine—CYP2A6—Dexamethasone—psoriasis	0.0129	0.0182	CbGbCtD
Amlodipine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0128	0.018	CbGbCtD
Amlodipine—CYP3A4—Calcitriol—psoriasis	0.0116	0.0163	CbGbCtD
Amlodipine—CYP1A1—Dexamethasone—psoriasis	0.011	0.0156	CbGbCtD
Amlodipine—CYP3A5—Hydrocortisone—psoriasis	0.0106	0.015	CbGbCtD
Amlodipine—CYP2C9—Cholecalciferol—psoriasis	0.0103	0.0145	CbGbCtD
Amlodipine—CYP2C8—Hydrocortisone—psoriasis	0.0102	0.0144	CbGbCtD
Amlodipine—CYP3A5—Cyclosporine—psoriasis	0.0101	0.0142	CbGbCtD
Amlodipine—CYP2C8—Cyclosporine—psoriasis	0.00967	0.0136	CbGbCtD
Amlodipine—CYP2D6—Cholecalciferol—psoriasis	0.00938	0.0132	CbGbCtD
Amlodipine—CYP3A4—Methoxsalen—psoriasis	0.00901	0.0127	CbGbCtD
Amlodipine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00883	0.0124	CbGbCtD
Amlodipine—CYP3A7—Dexamethasone—psoriasis	0.00883	0.0124	CbGbCtD
Amlodipine—ABCB1—Mycophenolate mofetil—psoriasis	0.00863	0.0122	CbGbCtD
Amlodipine—CYP2B6—Dexamethasone—psoriasis	0.0084	0.0119	CbGbCtD
Amlodipine—ABCB1—Betamethasone—psoriasis	0.00741	0.0104	CbGbCtD
Amlodipine—ABCB1—Prednisolone—psoriasis	0.00731	0.0103	CbGbCtD
Amlodipine—ABCB1—Hydrocortisone—psoriasis	0.00693	0.00977	CbGbCtD
Amlodipine—ABCB1—Prednisone—psoriasis	0.0069	0.00973	CbGbCtD
Amlodipine—CYP2C9—Cyclosporine—psoriasis	0.00674	0.00951	CbGbCtD
Amlodipine—CYP3A5—Dexamethasone—psoriasis	0.00662	0.00934	CbGbCtD
Amlodipine—ABCB1—Cyclosporine—psoriasis	0.00654	0.00923	CbGbCtD
Amlodipine—CYP2C8—Dexamethasone—psoriasis	0.00637	0.00898	CbGbCtD
Amlodipine—CYP2D6—Cyclosporine—psoriasis	0.00617	0.00869	CbGbCtD
Amlodipine—CYP3A4—Cholecalciferol—psoriasis	0.00597	0.00841	CbGbCtD
Amlodipine—CYP3A4—Triamcinolone—psoriasis	0.00517	0.00729	CbGbCtD
Amlodipine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00517	0.00729	CbGbCtD
Amlodipine—CYP2C9—Dexamethasone—psoriasis	0.00444	0.00626	CbGbCtD
Amlodipine—CYP3A4—Betamethasone—psoriasis	0.00444	0.00626	CbGbCtD
Amlodipine—CYP3A4—Prednisolone—psoriasis	0.00438	0.00618	CbGbCtD
Amlodipine—ABCB1—Dexamethasone—psoriasis	0.00431	0.00608	CbGbCtD
Amlodipine—CYP3A4—Hydrocortisone—psoriasis	0.00415	0.00585	CbGbCtD
Amlodipine—CYP3A4—Prednisone—psoriasis	0.00414	0.00583	CbGbCtD
Amlodipine—CYP2D6—Dexamethasone—psoriasis	0.00406	0.00573	CbGbCtD
Amlodipine—CYP3A4—Cyclosporine—psoriasis	0.00392	0.00553	CbGbCtD
Amlodipine—ABCB1—Methotrexate—psoriasis	0.00346	0.00488	CbGbCtD
Amlodipine—CYP3A4—Dexamethasone—psoriasis	0.00258	0.00364	CbGbCtD
Amlodipine—CACNA2D3—tendon—psoriasis	0.00151	0.0578	CbGeAlD
Amlodipine—SMPD1—skin of body—psoriasis	0.0015	0.0573	CbGeAlD
Amlodipine—CYP1A1—skin epidermis—psoriasis	0.00135	0.0515	CbGeAlD
Amlodipine—CACNA1S—tendon—psoriasis	0.00131	0.0498	CbGeAlD
Amlodipine—SMPD1—tendon—psoriasis	0.00114	0.0436	CbGeAlD
Amlodipine—CACNB2—tendon—psoriasis	0.000784	0.0299	CbGeAlD
Amlodipine—CACNA2D1—tendon—psoriasis	0.000737	0.0281	CbGeAlD
Amlodipine—CYP1A1—skin of body—psoriasis	0.000418	0.016	CbGeAlD
Amlodipine—CYP2B6—skin of body—psoriasis	0.000407	0.0155	CbGeAlD
Amlodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00015	0.00288	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—CYP2S1—psoriasis	0.000149	0.00286	CbGpPWpGaD
Amlodipine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000149	0.00285	CbGpPWpGaD
Amlodipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000148	0.00284	CbGpPWpGaD
Amlodipine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000147	0.00281	CbGpPWpGaD
Amlodipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.000145	0.00278	CbGpPWpGaD
Amlodipine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000143	0.00273	CbGpPWpGaD
Amlodipine—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.00014	0.00268	CbGpPWpGaD
Amlodipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000138	0.00265	CbGpPWpGaD
Amlodipine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000131	0.0025	CbGpPWpGaD
Amlodipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000129	0.00247	CbGpPWpGaD
Amlodipine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000122	0.00234	CbGpPWpGaD
Amlodipine—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000121	0.00232	CbGpPWpGaD
Amlodipine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000121	0.00232	CbGpPWpGaD
Amlodipine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000121	0.00231	CbGpPWpGaD
Amlodipine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000119	0.00229	CbGpPWpGaD
Amlodipine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000118	0.00227	CbGpPWpGaD
Amlodipine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000118	0.00226	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000115	0.00221	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—CARM1—psoriasis	0.000114	0.00219	CbGpPWpGaD
Amlodipine—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000113	0.00217	CbGpPWpGaD
Amlodipine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000111	0.00212	CbGpPWpGaD
Amlodipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00011	0.00211	CbGpPWpGaD
Amlodipine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.00011	0.00211	CbGpPWpGaD
Amlodipine—ABCB1—Allograft Rejection—IL13—psoriasis	0.00011	0.0021	CbGpPWpGaD
Amlodipine—CACNA1S—Alzheimers Disease—TNF—psoriasis	0.000109	0.0021	CbGpPWpGaD
Amlodipine—CA1—Metabolism—NDUFA5—psoriasis	0.000109	0.00208	CbGpPWpGaD
Amlodipine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000104	0.00198	CbGpPWpGaD
Amlodipine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000102	0.00195	CbGpPWpGaD
Amlodipine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000102	0.00195	CbGpPWpGaD
Amlodipine—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000101	0.00193	CbGpPWpGaD
Amlodipine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.0001	0.00192	CbGpPWpGaD
Amlodipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—psoriasis	9.96e-05	0.00191	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—CARM1—psoriasis	9.8e-05	0.00188	CbGpPWpGaD
Amlodipine—CACNA1S—Alzheimers Disease—TP53—psoriasis	9.65e-05	0.00185	CbGpPWpGaD
Amlodipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.64e-05	0.00185	CbGpPWpGaD
Amlodipine—Gastrointestinal pain—Cyclosporine—psoriasis	9.49e-05	0.000447	CcSEcCtD
Amlodipine—Loss of consciousness—Betamethasone—psoriasis	9.49e-05	0.000447	CcSEcCtD
Amlodipine—Loss of consciousness—Dexamethasone—psoriasis	9.49e-05	0.000447	CcSEcCtD
Amlodipine—Dizziness—Mycophenolic acid—psoriasis	9.48e-05	0.000446	CcSEcCtD
Amlodipine—Epistaxis—Methotrexate—psoriasis	9.48e-05	0.000446	CcSEcCtD
Amlodipine—Paraesthesia—Prednisolone—psoriasis	9.48e-05	0.000446	CcSEcCtD
Amlodipine—Tachycardia—Triamcinolone—psoriasis	9.47e-05	0.000446	CcSEcCtD
Amlodipine—Mental disorder—Prednisone—psoriasis	9.46e-05	0.000445	CcSEcCtD
Amlodipine—Malnutrition—Prednisone—psoriasis	9.4e-05	0.000443	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.39e-05	0.000442	CcSEcCtD
Amlodipine—Hyperhidrosis—Triamcinolone—psoriasis	9.39e-05	0.000442	CcSEcCtD
Amlodipine—CACNB2—Metabolism—NDUFA5—psoriasis	9.38e-05	0.0018	CbGpPWpGaD
Amlodipine—ABCB1—Allograft Rejection—IL12B—psoriasis	9.38e-05	0.00179	CbGpPWpGaD
Amlodipine—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	9.36e-05	0.00179	CbGpPWpGaD
Amlodipine—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.33e-05	0.000439	CcSEcCtD
Amlodipine—Insomnia—Hydrocortisone—psoriasis	9.33e-05	0.000439	CcSEcCtD
Amlodipine—CACNA1D—Developmental Biology—CARM1—psoriasis	9.28e-05	0.00178	CbGpPWpGaD
Amlodipine—Paraesthesia—Hydrocortisone—psoriasis	9.26e-05	0.000436	CcSEcCtD
Amlodipine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.25e-05	0.000436	CcSEcCtD
Amlodipine—CA1—Metabolism—CYP2S1—psoriasis	9.23e-05	0.00177	CbGpPWpGaD
Amlodipine—Urticaria—Cyclosporine—psoriasis	9.22e-05	0.000434	CcSEcCtD
Amlodipine—Myalgia—Dexamethasone—psoriasis	9.19e-05	0.000433	CcSEcCtD
Amlodipine—Myalgia—Betamethasone—psoriasis	9.19e-05	0.000433	CcSEcCtD
Amlodipine—Abdominal pain—Cyclosporine—psoriasis	9.17e-05	0.000432	CcSEcCtD
Amlodipine—Anxiety—Dexamethasone—psoriasis	9.16e-05	0.000431	CcSEcCtD
Amlodipine—Anxiety—Betamethasone—psoriasis	9.16e-05	0.000431	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.15e-05	0.00175	CbGpPWpGaD
Amlodipine—Vomiting—Mycophenolic acid—psoriasis	9.12e-05	0.000429	CcSEcCtD
Amlodipine—CYP1A1—Oxidative Stress—NFKB1—psoriasis	9.11e-05	0.00174	CbGpPWpGaD
Amlodipine—Discomfort—Dexamethasone—psoriasis	9.08e-05	0.000427	CcSEcCtD
Amlodipine—Discomfort—Betamethasone—psoriasis	9.08e-05	0.000427	CcSEcCtD
Amlodipine—Dyspepsia—Hydrocortisone—psoriasis	9.08e-05	0.000427	CcSEcCtD
Amlodipine—Haemoglobin—Methotrexate—psoriasis	9.07e-05	0.000427	CcSEcCtD
Amlodipine—Rash—Mycophenolic acid—psoriasis	9.04e-05	0.000426	CcSEcCtD
Amlodipine—Dermatitis—Mycophenolic acid—psoriasis	9.03e-05	0.000425	CcSEcCtD
Amlodipine—Pain—Prednisolone—psoriasis	9.03e-05	0.000425	CcSEcCtD
Amlodipine—Haemorrhage—Methotrexate—psoriasis	9.02e-05	0.000425	CcSEcCtD
Amlodipine—Hepatitis—Methotrexate—psoriasis	9.02e-05	0.000425	CcSEcCtD
Amlodipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.01e-05	0.00172	CbGpPWpGaD
Amlodipine—Urticaria—Mycophenolate mofetil—psoriasis	8.99e-05	0.000423	CcSEcCtD
Amlodipine—Headache—Mycophenolic acid—psoriasis	8.98e-05	0.000423	CcSEcCtD
Amlodipine—Decreased appetite—Hydrocortisone—psoriasis	8.96e-05	0.000422	CcSEcCtD
Amlodipine—Abdominal pain—Mycophenolate mofetil—psoriasis	8.95e-05	0.000421	CcSEcCtD
Amlodipine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	8.93e-05	0.00171	CbGpPWpGaD
Amlodipine—Urinary tract disorder—Methotrexate—psoriasis	8.91e-05	0.00042	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.9e-05	0.000419	CcSEcCtD
Amlodipine—CACNA1D—Alzheimers Disease—TNF—psoriasis	8.89e-05	0.0017	CbGpPWpGaD
Amlodipine—Fatigue—Hydrocortisone—psoriasis	8.89e-05	0.000419	CcSEcCtD
Amlodipine—CACNA1D—Metabolism—NDUFA5—psoriasis	8.89e-05	0.0017	CbGpPWpGaD
Amlodipine—Urethral disorder—Methotrexate—psoriasis	8.85e-05	0.000416	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.84e-05	0.000416	CcSEcCtD
Amlodipine—Pain—Hydrocortisone—psoriasis	8.82e-05	0.000415	CcSEcCtD
Amlodipine—Oedema—Dexamethasone—psoriasis	8.81e-05	0.000415	CcSEcCtD
Amlodipine—Oedema—Betamethasone—psoriasis	8.81e-05	0.000415	CcSEcCtD
Amlodipine—Insomnia—Triamcinolone—psoriasis	8.78e-05	0.000413	CcSEcCtD
Amlodipine—Ill-defined disorder—Prednisone—psoriasis	8.72e-05	0.000411	CcSEcCtD
Amlodipine—Paraesthesia—Triamcinolone—psoriasis	8.72e-05	0.00041	CcSEcCtD
Amlodipine—Feeling abnormal—Prednisolone—psoriasis	8.7e-05	0.00041	CcSEcCtD
Amlodipine—Visual impairment—Methotrexate—psoriasis	8.7e-05	0.000409	CcSEcCtD
Amlodipine—Shock—Dexamethasone—psoriasis	8.67e-05	0.000408	CcSEcCtD
Amlodipine—Shock—Betamethasone—psoriasis	8.67e-05	0.000408	CcSEcCtD
Amlodipine—Dyspnoea—Triamcinolone—psoriasis	8.66e-05	0.000408	CcSEcCtD
Amlodipine—Nervous system disorder—Dexamethasone—psoriasis	8.64e-05	0.000407	CcSEcCtD
Amlodipine—Nervous system disorder—Betamethasone—psoriasis	8.64e-05	0.000407	CcSEcCtD
Amlodipine—Agitation—Prednisone—psoriasis	8.64e-05	0.000407	CcSEcCtD
Amlodipine—Thrombocytopenia—Betamethasone—psoriasis	8.62e-05	0.000406	CcSEcCtD
Amlodipine—Thrombocytopenia—Dexamethasone—psoriasis	8.62e-05	0.000406	CcSEcCtD
Amlodipine—Tachycardia—Dexamethasone—psoriasis	8.6e-05	0.000405	CcSEcCtD
Amlodipine—Tachycardia—Betamethasone—psoriasis	8.6e-05	0.000405	CcSEcCtD
Amlodipine—Angioedema—Prednisone—psoriasis	8.59e-05	0.000404	CcSEcCtD
Amlodipine—Hypersensitivity—Cyclosporine—psoriasis	8.55e-05	0.000402	CcSEcCtD
Amlodipine—Dyspepsia—Triamcinolone—psoriasis	8.55e-05	0.000402	CcSEcCtD
Amlodipine—CACNB2—NCAM signaling for neurite out-growth—IL6—psoriasis	8.54e-05	0.00163	CbGpPWpGaD
Amlodipine—Erythema multiforme—Methotrexate—psoriasis	8.53e-05	0.000402	CcSEcCtD
Amlodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.52e-05	0.00163	CbGpPWpGaD
Amlodipine—Nausea—Mycophenolic acid—psoriasis	8.52e-05	0.000401	CcSEcCtD
Amlodipine—Hyperhidrosis—Betamethasone—psoriasis	8.52e-05	0.000401	CcSEcCtD
Amlodipine—Hyperhidrosis—Dexamethasone—psoriasis	8.52e-05	0.000401	CcSEcCtD
Amlodipine—Feeling abnormal—Hydrocortisone—psoriasis	8.5e-05	0.0004	CcSEcCtD
Amlodipine—Malaise—Prednisone—psoriasis	8.48e-05	0.000399	CcSEcCtD
Amlodipine—Vertigo—Prednisone—psoriasis	8.44e-05	0.000398	CcSEcCtD
Amlodipine—Eye disorder—Methotrexate—psoriasis	8.43e-05	0.000397	CcSEcCtD
Amlodipine—Gastrointestinal pain—Hydrocortisone—psoriasis	8.43e-05	0.000397	CcSEcCtD
Amlodipine—Syncope—Prednisone—psoriasis	8.43e-05	0.000397	CcSEcCtD
Amlodipine—Tinnitus—Methotrexate—psoriasis	8.41e-05	0.000396	CcSEcCtD
Amlodipine—Anorexia—Betamethasone—psoriasis	8.4e-05	0.000395	CcSEcCtD
Amlodipine—Anorexia—Dexamethasone—psoriasis	8.4e-05	0.000395	CcSEcCtD
Amlodipine—Urticaria—Prednisolone—psoriasis	8.39e-05	0.000395	CcSEcCtD
Amlodipine—Cardiac disorder—Methotrexate—psoriasis	8.37e-05	0.000394	CcSEcCtD
Amlodipine—Fatigue—Triamcinolone—psoriasis	8.37e-05	0.000394	CcSEcCtD
Amlodipine—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.34e-05	0.000393	CcSEcCtD
Amlodipine—Asthenia—Cyclosporine—psoriasis	8.32e-05	0.000392	CcSEcCtD
Amlodipine—Pain—Triamcinolone—psoriasis	8.3e-05	0.000391	CcSEcCtD
Amlodipine—Loss of consciousness—Prednisone—psoriasis	8.26e-05	0.000389	CcSEcCtD
Amlodipine—Pruritus—Cyclosporine—psoriasis	8.21e-05	0.000386	CcSEcCtD
Amlodipine—Urticaria—Hydrocortisone—psoriasis	8.19e-05	0.000386	CcSEcCtD
Amlodipine—Angiopathy—Methotrexate—psoriasis	8.19e-05	0.000385	CcSEcCtD
Amlodipine—CACNA1C—Developmental Biology—CARM1—psoriasis	8.15e-05	0.00156	CbGpPWpGaD
Amlodipine—Immune system disorder—Methotrexate—psoriasis	8.15e-05	0.000384	CcSEcCtD
Amlodipine—Abdominal pain—Hydrocortisone—psoriasis	8.15e-05	0.000384	CcSEcCtD
Amlodipine—Mediastinal disorder—Methotrexate—psoriasis	8.13e-05	0.000383	CcSEcCtD
Amlodipine—Asthenia—Mycophenolate mofetil—psoriasis	8.12e-05	0.000382	CcSEcCtD
Amlodipine—Chills—Methotrexate—psoriasis	8.1e-05	0.000381	CcSEcCtD
Amlodipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—psoriasis	8.09e-05	0.00155	CbGpPWpGaD
Amlodipine—Musculoskeletal discomfort—Betamethasone—psoriasis	8.03e-05	0.000378	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.03e-05	0.000378	CcSEcCtD
Amlodipine—Pruritus—Mycophenolate mofetil—psoriasis	8.01e-05	0.000377	CcSEcCtD
Amlodipine—Myalgia—Prednisone—psoriasis	8e-05	0.000377	CcSEcCtD
Amlodipine—Arthralgia—Prednisone—psoriasis	8e-05	0.000377	CcSEcCtD
Amlodipine—Feeling abnormal—Triamcinolone—psoriasis	8e-05	0.000377	CcSEcCtD
Amlodipine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.99e-05	0.00153	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—CYP2S1—psoriasis	7.98e-05	0.00153	CbGpPWpGaD
Amlodipine—Anxiety—Prednisone—psoriasis	7.97e-05	0.000375	CcSEcCtD
Amlodipine—Alopecia—Methotrexate—psoriasis	7.97e-05	0.000375	CcSEcCtD
Amlodipine—Insomnia—Dexamethasone—psoriasis	7.97e-05	0.000375	CcSEcCtD
Amlodipine—Insomnia—Betamethasone—psoriasis	7.97e-05	0.000375	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.95e-05	0.000374	CcSEcCtD
Amlodipine—Diarrhoea—Cyclosporine—psoriasis	7.94e-05	0.000374	CcSEcCtD
Amlodipine—Paraesthesia—Dexamethasone—psoriasis	7.91e-05	0.000372	CcSEcCtD
Amlodipine—Paraesthesia—Betamethasone—psoriasis	7.91e-05	0.000372	CcSEcCtD
Amlodipine—Discomfort—Prednisone—psoriasis	7.91e-05	0.000372	CcSEcCtD
Amlodipine—Mental disorder—Methotrexate—psoriasis	7.91e-05	0.000372	CcSEcCtD
Amlodipine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.88e-05	0.00151	CbGpPWpGaD
Amlodipine—Malnutrition—Methotrexate—psoriasis	7.86e-05	0.00037	CcSEcCtD
Amlodipine—CACNA1D—Alzheimers Disease—TP53—psoriasis	7.84e-05	0.0015	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.83e-05	0.0015	CbGpPWpGaD
Amlodipine—CACNA1C—Alzheimers Disease—TNF—psoriasis	7.81e-05	0.0015	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—NDUFA5—psoriasis	7.81e-05	0.00149	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.78e-05	0.00149	CbGpPWpGaD
Amlodipine—Hypersensitivity—Prednisolone—psoriasis	7.78e-05	0.000366	CcSEcCtD
Amlodipine—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	7.77e-05	0.00149	CbGpPWpGaD
Amlodipine—Dyspepsia—Betamethasone—psoriasis	7.75e-05	0.000365	CcSEcCtD
Amlodipine—Dyspepsia—Dexamethasone—psoriasis	7.75e-05	0.000365	CcSEcCtD
Amlodipine—Diarrhoea—Mycophenolate mofetil—psoriasis	7.74e-05	0.000365	CcSEcCtD
Amlodipine—Urticaria—Triamcinolone—psoriasis	7.71e-05	0.000363	CcSEcCtD
Amlodipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.7e-05	0.00147	CbGpPWpGaD
Amlodipine—Dysgeusia—Methotrexate—psoriasis	7.69e-05	0.000362	CcSEcCtD
Amlodipine—Dizziness—Cyclosporine—psoriasis	7.67e-05	0.000361	CcSEcCtD
Amlodipine—Oedema—Prednisone—psoriasis	7.67e-05	0.000361	CcSEcCtD
Amlodipine—Decreased appetite—Dexamethasone—psoriasis	7.66e-05	0.000361	CcSEcCtD
Amlodipine—Decreased appetite—Betamethasone—psoriasis	7.66e-05	0.000361	CcSEcCtD
Amlodipine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	7.65e-05	0.00146	CbGpPWpGaD
Amlodipine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.6e-05	0.000358	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Betamethasone—psoriasis	7.6e-05	0.000358	CcSEcCtD
Amlodipine—Back pain—Methotrexate—psoriasis	7.6e-05	0.000358	CcSEcCtD
Amlodipine—Hypersensitivity—Hydrocortisone—psoriasis	7.6e-05	0.000358	CcSEcCtD
Amlodipine—Fatigue—Betamethasone—psoriasis	7.59e-05	0.000358	CcSEcCtD
Amlodipine—Fatigue—Dexamethasone—psoriasis	7.59e-05	0.000358	CcSEcCtD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.57e-05	0.00145	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—CYP2S1—psoriasis	7.56e-05	0.00145	CbGpPWpGaD
Amlodipine—Shock—Prednisone—psoriasis	7.55e-05	0.000355	CcSEcCtD
Amlodipine—Pain—Betamethasone—psoriasis	7.53e-05	0.000355	CcSEcCtD
Amlodipine—Pain—Dexamethasone—psoriasis	7.53e-05	0.000355	CcSEcCtD
Amlodipine—Nervous system disorder—Prednisone—psoriasis	7.52e-05	0.000354	CcSEcCtD
Amlodipine—Tachycardia—Prednisone—psoriasis	7.49e-05	0.000353	CcSEcCtD
Amlodipine—Dizziness—Mycophenolate mofetil—psoriasis	7.48e-05	0.000352	CcSEcCtD
Amlodipine—Skin disorder—Prednisone—psoriasis	7.45e-05	0.000351	CcSEcCtD
Amlodipine—Hyperhidrosis—Prednisone—psoriasis	7.42e-05	0.000349	CcSEcCtD
Amlodipine—Asthenia—Hydrocortisone—psoriasis	7.4e-05	0.000348	CcSEcCtD
Amlodipine—Vomiting—Cyclosporine—psoriasis	7.38e-05	0.000347	CcSEcCtD
Amlodipine—Rash—Cyclosporine—psoriasis	7.31e-05	0.000344	CcSEcCtD
Amlodipine—Anorexia—Prednisone—psoriasis	7.31e-05	0.000344	CcSEcCtD
Amlodipine—Dermatitis—Cyclosporine—psoriasis	7.31e-05	0.000344	CcSEcCtD
Amlodipine—SMPD1—Metabolism—CARM1—psoriasis	7.3e-05	0.0014	CbGpPWpGaD
Amlodipine—Pruritus—Hydrocortisone—psoriasis	7.29e-05	0.000343	CcSEcCtD
Amlodipine—Ill-defined disorder—Methotrexate—psoriasis	7.29e-05	0.000343	CcSEcCtD
Amlodipine—Headache—Cyclosporine—psoriasis	7.27e-05	0.000342	CcSEcCtD
Amlodipine—Feeling abnormal—Dexamethasone—psoriasis	7.26e-05	0.000342	CcSEcCtD
Amlodipine—Feeling abnormal—Betamethasone—psoriasis	7.26e-05	0.000342	CcSEcCtD
Amlodipine—Gastrointestinal pain—Betamethasone—psoriasis	7.2e-05	0.000339	CcSEcCtD
Amlodipine—Gastrointestinal pain—Dexamethasone—psoriasis	7.2e-05	0.000339	CcSEcCtD
Amlodipine—Vomiting—Mycophenolate mofetil—psoriasis	7.2e-05	0.000339	CcSEcCtD
Amlodipine—Hypersensitivity—Triamcinolone—psoriasis	7.15e-05	0.000337	CcSEcCtD
Amlodipine—Rash—Mycophenolate mofetil—psoriasis	7.14e-05	0.000336	CcSEcCtD
Amlodipine—Dermatitis—Mycophenolate mofetil—psoriasis	7.13e-05	0.000336	CcSEcCtD
Amlodipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—psoriasis	7.11e-05	0.00136	CbGpPWpGaD
Amlodipine—Headache—Mycophenolate mofetil—psoriasis	7.09e-05	0.000334	CcSEcCtD
Amlodipine—Malaise—Methotrexate—psoriasis	7.08e-05	0.000334	CcSEcCtD
Amlodipine—Vertigo—Methotrexate—psoriasis	7.06e-05	0.000332	CcSEcCtD
Amlodipine—Diarrhoea—Hydrocortisone—psoriasis	7.05e-05	0.000332	CcSEcCtD
Amlodipine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	7.05e-05	0.00135	CbGpPWpGaD
Amlodipine—Leukopenia—Methotrexate—psoriasis	7.03e-05	0.000331	CcSEcCtD
Amlodipine—Urticaria—Betamethasone—psoriasis	7e-05	0.000329	CcSEcCtD
Amlodipine—Urticaria—Dexamethasone—psoriasis	7e-05	0.000329	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Prednisone—psoriasis	6.99e-05	0.000329	CcSEcCtD
Amlodipine—Dizziness—Prednisolone—psoriasis	6.98e-05	0.000329	CcSEcCtD
Amlodipine—Asthenia—Triamcinolone—psoriasis	6.97e-05	0.000328	CcSEcCtD
Amlodipine—Abdominal pain—Dexamethasone—psoriasis	6.96e-05	0.000328	CcSEcCtD
Amlodipine—Abdominal pain—Betamethasone—psoriasis	6.96e-05	0.000328	CcSEcCtD
Amlodipine—Insomnia—Prednisone—psoriasis	6.94e-05	0.000327	CcSEcCtD
Amlodipine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.89e-05	0.00132	CbGpPWpGaD
Amlodipine—Nausea—Cyclosporine—psoriasis	6.89e-05	0.000324	CcSEcCtD
Amlodipine—Paraesthesia—Prednisone—psoriasis	6.89e-05	0.000324	CcSEcCtD
Amlodipine—CACNA1C—Alzheimers Disease—TP53—psoriasis	6.89e-05	0.00132	CbGpPWpGaD
Amlodipine—Pruritus—Triamcinolone—psoriasis	6.87e-05	0.000323	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—IL10—psoriasis	6.85e-05	0.00131	CbGpPWpGaD
Amlodipine—Cough—Methotrexate—psoriasis	6.85e-05	0.000323	CcSEcCtD
Amlodipine—SMPD1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.82e-05	0.00131	CbGpPWpGaD
Amlodipine—Dizziness—Hydrocortisone—psoriasis	6.82e-05	0.000321	CcSEcCtD
Amlodipine—Dyspepsia—Prednisone—psoriasis	6.75e-05	0.000318	CcSEcCtD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.72e-05	0.00129	CbGpPWpGaD
Amlodipine—Nausea—Mycophenolate mofetil—psoriasis	6.72e-05	0.000316	CcSEcCtD
Amlodipine—Myalgia—Methotrexate—psoriasis	6.69e-05	0.000315	CcSEcCtD
Amlodipine—Arthralgia—Methotrexate—psoriasis	6.69e-05	0.000315	CcSEcCtD
Amlodipine—Chest pain—Methotrexate—psoriasis	6.69e-05	0.000315	CcSEcCtD
Amlodipine—Decreased appetite—Prednisone—psoriasis	6.67e-05	0.000314	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—IL4—psoriasis	6.67e-05	0.00128	CbGpPWpGaD
Amlodipine—Rash—Prednisolone—psoriasis	6.66e-05	0.000313	CcSEcCtD
Amlodipine—Dermatitis—Prednisolone—psoriasis	6.65e-05	0.000313	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.64e-05	0.000313	CcSEcCtD
Amlodipine—CACNA1C—Metabolism—CYP2S1—psoriasis	6.64e-05	0.00127	CbGpPWpGaD
Amlodipine—Fatigue—Prednisone—psoriasis	6.61e-05	0.000311	CcSEcCtD
Amlodipine—Headache—Prednisolone—psoriasis	6.61e-05	0.000311	CcSEcCtD
Amlodipine—Discomfort—Methotrexate—psoriasis	6.61e-05	0.000311	CcSEcCtD
Amlodipine—Constipation—Prednisone—psoriasis	6.56e-05	0.000309	CcSEcCtD
Amlodipine—Vomiting—Hydrocortisone—psoriasis	6.56e-05	0.000309	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.52e-05	0.00125	CbGpPWpGaD
Amlodipine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.51e-05	0.00125	CbGpPWpGaD
Amlodipine—Rash—Hydrocortisone—psoriasis	6.5e-05	0.000306	CcSEcCtD
Amlodipine—Dermatitis—Hydrocortisone—psoriasis	6.49e-05	0.000306	CcSEcCtD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.47e-05	0.00124	CbGpPWpGaD
Amlodipine—Headache—Hydrocortisone—psoriasis	6.46e-05	0.000304	CcSEcCtD
Amlodipine—Dizziness—Triamcinolone—psoriasis	6.42e-05	0.000302	CcSEcCtD
Amlodipine—Feeling abnormal—Prednisone—psoriasis	6.32e-05	0.000298	CcSEcCtD
Amlodipine—Asthenia—Dexamethasone—psoriasis	6.32e-05	0.000298	CcSEcCtD
Amlodipine—Asthenia—Betamethasone—psoriasis	6.32e-05	0.000298	CcSEcCtD
Amlodipine—Nervous system disorder—Methotrexate—psoriasis	6.29e-05	0.000296	CcSEcCtD
Amlodipine—Thrombocytopenia—Methotrexate—psoriasis	6.28e-05	0.000296	CcSEcCtD
Amlodipine—Gastrointestinal pain—Prednisone—psoriasis	6.27e-05	0.000295	CcSEcCtD
Amlodipine—Nausea—Prednisolone—psoriasis	6.27e-05	0.000295	CcSEcCtD
Amlodipine—Pruritus—Betamethasone—psoriasis	6.23e-05	0.000293	CcSEcCtD
Amlodipine—Pruritus—Dexamethasone—psoriasis	6.23e-05	0.000293	CcSEcCtD
Amlodipine—Skin disorder—Methotrexate—psoriasis	6.23e-05	0.000293	CcSEcCtD
Amlodipine—Hyperhidrosis—Methotrexate—psoriasis	6.2e-05	0.000292	CcSEcCtD
Amlodipine—Vomiting—Triamcinolone—psoriasis	6.17e-05	0.000291	CcSEcCtD
Amlodipine—Nausea—Hydrocortisone—psoriasis	6.12e-05	0.000288	CcSEcCtD
Amlodipine—Rash—Triamcinolone—psoriasis	6.12e-05	0.000288	CcSEcCtD
Amlodipine—Dermatitis—Triamcinolone—psoriasis	6.12e-05	0.000288	CcSEcCtD
Amlodipine—Anorexia—Methotrexate—psoriasis	6.11e-05	0.000288	CcSEcCtD
Amlodipine—Urticaria—Prednisone—psoriasis	6.09e-05	0.000287	CcSEcCtD
Amlodipine—Headache—Triamcinolone—psoriasis	6.08e-05	0.000286	CcSEcCtD
Amlodipine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.07e-05	0.00116	CbGpPWpGaD
Amlodipine—Abdominal pain—Prednisone—psoriasis	6.06e-05	0.000286	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.04e-05	0.00116	CbGpPWpGaD
Amlodipine—Diarrhoea—Dexamethasone—psoriasis	6.03e-05	0.000284	CcSEcCtD
Amlodipine—Diarrhoea—Betamethasone—psoriasis	6.03e-05	0.000284	CcSEcCtD
Amlodipine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	5.97e-05	0.00114	CbGpPWpGaD
Amlodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.94e-05	0.00114	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.87e-05	0.00112	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—TYK2—psoriasis	5.84e-05	0.00112	CbGpPWpGaD
Amlodipine—Musculoskeletal discomfort—Methotrexate—psoriasis	5.84e-05	0.000275	CcSEcCtD
Amlodipine—Dizziness—Betamethasone—psoriasis	5.82e-05	0.000274	CcSEcCtD
Amlodipine—Dizziness—Dexamethasone—psoriasis	5.82e-05	0.000274	CcSEcCtD
Amlodipine—Insomnia—Methotrexate—psoriasis	5.8e-05	0.000273	CcSEcCtD
Amlodipine—Nausea—Triamcinolone—psoriasis	5.77e-05	0.000272	CcSEcCtD
Amlodipine—Paraesthesia—Methotrexate—psoriasis	5.76e-05	0.000271	CcSEcCtD
Amlodipine—Dyspnoea—Methotrexate—psoriasis	5.72e-05	0.000269	CcSEcCtD
Amlodipine—Somnolence—Methotrexate—psoriasis	5.7e-05	0.000268	CcSEcCtD
Amlodipine—Hypersensitivity—Prednisone—psoriasis	5.65e-05	0.000266	CcSEcCtD
Amlodipine—Dyspepsia—Methotrexate—psoriasis	5.64e-05	0.000266	CcSEcCtD
Amlodipine—Vomiting—Betamethasone—psoriasis	5.6e-05	0.000264	CcSEcCtD
Amlodipine—Vomiting—Dexamethasone—psoriasis	5.6e-05	0.000264	CcSEcCtD
Amlodipine—Decreased appetite—Methotrexate—psoriasis	5.57e-05	0.000262	CcSEcCtD
Amlodipine—Rash—Dexamethasone—psoriasis	5.55e-05	0.000261	CcSEcCtD
Amlodipine—Rash—Betamethasone—psoriasis	5.55e-05	0.000261	CcSEcCtD
Amlodipine—Dermatitis—Betamethasone—psoriasis	5.55e-05	0.000261	CcSEcCtD
Amlodipine—Dermatitis—Dexamethasone—psoriasis	5.55e-05	0.000261	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Methotrexate—psoriasis	5.53e-05	0.000261	CcSEcCtD
Amlodipine—Fatigue—Methotrexate—psoriasis	5.53e-05	0.00026	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.52e-05	0.00106	CbGpPWpGaD
Amlodipine—Headache—Betamethasone—psoriasis	5.52e-05	0.00026	CcSEcCtD
Amlodipine—Headache—Dexamethasone—psoriasis	5.52e-05	0.00026	CcSEcCtD
Amlodipine—Asthenia—Prednisone—psoriasis	5.5e-05	0.000259	CcSEcCtD
Amlodipine—Pain—Methotrexate—psoriasis	5.48e-05	0.000258	CcSEcCtD
Amlodipine—CACNA1S—Developmental Biology—LEP—psoriasis	5.46e-05	0.00105	CbGpPWpGaD
Amlodipine—Pruritus—Prednisone—psoriasis	5.43e-05	0.000256	CcSEcCtD
Amlodipine—Feeling abnormal—Methotrexate—psoriasis	5.28e-05	0.000249	CcSEcCtD
Amlodipine—Diarrhoea—Prednisone—psoriasis	5.25e-05	0.000247	CcSEcCtD
Amlodipine—Gastrointestinal pain—Methotrexate—psoriasis	5.24e-05	0.000247	CcSEcCtD
Amlodipine—Nausea—Dexamethasone—psoriasis	5.23e-05	0.000246	CcSEcCtD
Amlodipine—Nausea—Betamethasone—psoriasis	5.23e-05	0.000246	CcSEcCtD
Amlodipine—Urticaria—Methotrexate—psoriasis	5.09e-05	0.00024	CcSEcCtD
Amlodipine—Dizziness—Prednisone—psoriasis	5.07e-05	0.000239	CcSEcCtD
Amlodipine—Abdominal pain—Methotrexate—psoriasis	5.07e-05	0.000239	CcSEcCtD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.03e-05	0.000964	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.03e-05	0.000964	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—TYK2—psoriasis	5.01e-05	0.000959	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.96e-05	0.000949	CbGpPWpGaD
Amlodipine—Vomiting—Prednisone—psoriasis	4.88e-05	0.00023	CcSEcCtD
Amlodipine—Rash—Prednisone—psoriasis	4.84e-05	0.000228	CcSEcCtD
Amlodipine—Dermatitis—Prednisone—psoriasis	4.83e-05	0.000228	CcSEcCtD
Amlodipine—Headache—Prednisone—psoriasis	4.81e-05	0.000226	CcSEcCtD
Amlodipine—CYP3A7—Metabolism—NDUFA5—psoriasis	4.78e-05	0.000915	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—PPARG—psoriasis	4.76e-05	0.000911	CbGpPWpGaD
Amlodipine—CACNA1D—Axon guidance—TYK2—psoriasis	4.74e-05	0.000908	CbGpPWpGaD
Amlodipine—Hypersensitivity—Methotrexate—psoriasis	4.72e-05	0.000222	CcSEcCtD
Amlodipine—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	4.72e-05	0.000903	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—LEP—psoriasis	4.68e-05	0.000896	CbGpPWpGaD
Amlodipine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	4.62e-05	0.000884	CbGpPWpGaD
Amlodipine—Asthenia—Methotrexate—psoriasis	4.6e-05	0.000217	CcSEcCtD
Amlodipine—Nausea—Prednisone—psoriasis	4.56e-05	0.000215	CcSEcCtD
Amlodipine—Pruritus—Methotrexate—psoriasis	4.54e-05	0.000214	CcSEcCtD
Amlodipine—CA1—Metabolism—CARM1—psoriasis	4.51e-05	0.000863	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—CAT—psoriasis	4.49e-05	0.000859	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—LEP—psoriasis	4.43e-05	0.000849	CbGpPWpGaD
Amlodipine—Diarrhoea—Methotrexate—psoriasis	4.39e-05	0.000207	CcSEcCtD
Amlodipine—CYP2A6—Metabolism—NDUFA5—psoriasis	4.38e-05	0.000839	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.29e-05	0.000821	CbGpPWpGaD
Amlodipine—Dizziness—Methotrexate—psoriasis	4.24e-05	0.0002	CcSEcCtD
Amlodipine—CACNA1S—Developmental Biology—TYK2—psoriasis	4.17e-05	0.000798	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—TYK2—psoriasis	4.17e-05	0.000798	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—VEGFA—psoriasis	4.13e-05	0.000791	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.13e-05	0.00079	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—PPARG—psoriasis	4.08e-05	0.000781	CbGpPWpGaD
Amlodipine—Vomiting—Methotrexate—psoriasis	4.08e-05	0.000192	CcSEcCtD
Amlodipine—CYP3A7—Metabolism—CYP2S1—psoriasis	4.07e-05	0.000778	CbGpPWpGaD
Amlodipine—Rash—Methotrexate—psoriasis	4.04e-05	0.00019	CcSEcCtD
Amlodipine—Dermatitis—Methotrexate—psoriasis	4.04e-05	0.00019	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—IFNG—psoriasis	4.03e-05	0.000772	CbGpPWpGaD
Amlodipine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.02e-05	0.00077	CbGpPWpGaD
Amlodipine—Headache—Methotrexate—psoriasis	4.02e-05	0.000189	CcSEcCtD
Amlodipine—CACNB2—Metabolism—CARM1—psoriasis	3.9e-05	0.000746	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—LEP—psoriasis	3.9e-05	0.000746	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—PPARG—psoriasis	3.86e-05	0.000739	CbGpPWpGaD
Amlodipine—Nausea—Methotrexate—psoriasis	3.81e-05	0.000179	CcSEcCtD
Amlodipine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.75e-05	0.000717	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.75e-05	0.000717	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CYP2S1—psoriasis	3.73e-05	0.000713	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—CARM1—psoriasis	3.69e-05	0.000706	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—TYK2—psoriasis	3.57e-05	0.000684	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—VEGFA—psoriasis	3.54e-05	0.000678	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—NDUFA5—psoriasis	3.54e-05	0.000677	CbGpPWpGaD
Amlodipine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.51e-05	0.000673	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—APOE—psoriasis	3.49e-05	0.000668	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—NDUFA5—psoriasis	3.46e-05	0.000662	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—PPARG—psoriasis	3.39e-05	0.00065	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—TYK2—psoriasis	3.38e-05	0.000648	CbGpPWpGaD
Amlodipine—CACNA1D—Axon guidance—VEGFA—psoriasis	3.35e-05	0.000642	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—NDUFA5—psoriasis	3.27e-05	0.000625	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—NFKB1—psoriasis	3.25e-05	0.000622	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—CARM1—psoriasis	3.24e-05	0.000621	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.21e-05	0.000614	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.21e-05	0.000614	CbGpPWpGaD
Amlodipine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	3.18e-05	0.000609	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.09e-05	0.000591	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.04e-05	0.000583	CbGpPWpGaD
Amlodipine—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.04e-05	0.000583	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—PPARG—psoriasis	3.04e-05	0.000582	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CYP2S1—psoriasis	3.01e-05	0.000576	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—NDUFA5—psoriasis	2.99e-05	0.000573	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—TYK2—psoriasis	2.97e-05	0.000569	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—VEGFA—psoriasis	2.95e-05	0.000564	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—VEGFA—psoriasis	2.95e-05	0.000564	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CYP2S1—psoriasis	2.94e-05	0.000563	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—STAT3—psoriasis	2.92e-05	0.000559	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—IL6—psoriasis	2.86e-05	0.000547	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.79e-05	0.000534	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—NFKB1—psoriasis	2.78e-05	0.000533	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CYP2S1—psoriasis	2.78e-05	0.000531	CbGpPWpGaD
Amlodipine—CA1—Metabolism—CAT—psoriasis	2.77e-05	0.000531	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—NFKB1—psoriasis	2.64e-05	0.000505	CbGpPWpGaD
Amlodipine—ABCB1—Allograft Rejection—TNF—psoriasis	2.61e-05	0.000499	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—NDUFA5—psoriasis	2.61e-05	0.000499	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.59e-05	0.000496	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CYP2S1—psoriasis	2.55e-05	0.000487	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—VEGFA—psoriasis	2.53e-05	0.000484	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—TNF—psoriasis	2.53e-05	0.000484	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—STAT3—psoriasis	2.5e-05	0.000479	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—NDUFA5—psoriasis	2.46e-05	0.00047	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—IL6—psoriasis	2.45e-05	0.000469	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—NDUFA5—psoriasis	2.44e-05	0.000466	CbGpPWpGaD
Amlodipine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.42e-05	0.000464	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—CAT—psoriasis	2.4e-05	0.000459	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—VEGFA—psoriasis	2.39e-05	0.000458	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—STAT3—psoriasis	2.37e-05	0.000454	CbGpPWpGaD
Amlodipine—CACNA1D—Axon guidance—IL6—psoriasis	2.32e-05	0.000444	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—NFKB1—psoriasis	2.32e-05	0.000444	CbGpPWpGaD
Amlodipine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.31e-05	0.000443	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.27e-05	0.000435	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—CAT—psoriasis	2.27e-05	0.000434	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CYP2S1—psoriasis	2.22e-05	0.000425	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—TNF—psoriasis	2.17e-05	0.000415	CbGpPWpGaD
Amlodipine—CA1—Metabolism—APOE—psoriasis	2.15e-05	0.000412	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—VEGFA—psoriasis	2.1e-05	0.000403	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.09e-05	0.0004	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—STAT3—psoriasis	2.08e-05	0.000399	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—NDUFA5—psoriasis	2.08e-05	0.000399	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CYP2S1—psoriasis	2.07e-05	0.000397	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—TNF—psoriasis	2.05e-05	0.000393	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—IL6—psoriasis	2.04e-05	0.00039	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—IL6—psoriasis	2.04e-05	0.00039	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—CAT—psoriasis	1.99e-05	0.000382	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—CARM1—psoriasis	1.99e-05	0.00038	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.94e-05	0.000372	CbGpPWpGaD
Amlodipine—CA1—Metabolism—PPARG—psoriasis	1.88e-05	0.000359	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—APOE—psoriasis	1.86e-05	0.000356	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CARM1—psoriasis	1.82e-05	0.000348	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—TNF—psoriasis	1.8e-05	0.000345	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.77e-05	0.000339	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—APOE—psoriasis	1.76e-05	0.000338	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—IL6—psoriasis	1.75e-05	0.000335	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.72e-05	0.000329	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—IL6—psoriasis	1.66e-05	0.000317	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.66e-05	0.000317	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—PPARG—psoriasis	1.62e-05	0.00031	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.61e-05	0.000308	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—APOE—psoriasis	1.55e-05	0.000297	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PPARG—psoriasis	1.54e-05	0.000294	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.5e-05	0.000288	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CARM1—psoriasis	1.47e-05	0.000281	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.46e-05	0.000279	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—IL6—psoriasis	1.45e-05	0.000278	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CARM1—psoriasis	1.44e-05	0.000275	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.37e-05	0.000262	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CARM1—psoriasis	1.36e-05	0.00026	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PPARG—psoriasis	1.35e-05	0.000258	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.33e-05	0.000255	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.29e-05	0.000246	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.27e-05	0.000243	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CARM1—psoriasis	1.24e-05	0.000238	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—CAT—psoriasis	1.22e-05	0.000234	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.16e-05	0.000222	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.14e-05	0.000217	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CAT—psoriasis	1.12e-05	0.000214	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.09e-05	0.000208	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CARM1—psoriasis	1.08e-05	0.000207	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CARM1—psoriasis	1.02e-05	0.000195	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CARM1—psoriasis	1.01e-05	0.000194	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—APOE—psoriasis	9.49e-06	0.000182	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.46e-06	0.000181	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.28e-06	0.000178	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CAT—psoriasis	9.03e-06	0.000173	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CAT—psoriasis	8.83e-06	0.000169	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—APOE—psoriasis	8.7e-06	0.000166	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CARM1—psoriasis	8.65e-06	0.000165	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CAT—psoriasis	8.34e-06	0.00016	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PPARG—psoriasis	8.27e-06	0.000158	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.08e-06	0.000155	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CAT—psoriasis	7.65e-06	0.000146	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PPARG—psoriasis	7.58e-06	0.000145	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—APOE—psoriasis	7.02e-06	0.000134	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—APOE—psoriasis	6.86e-06	0.000131	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CARM1—psoriasis	6.67e-06	0.000128	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CAT—psoriasis	6.66e-06	0.000128	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—APOE—psoriasis	6.48e-06	0.000124	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CAT—psoriasis	6.28e-06	0.00012	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CAT—psoriasis	6.22e-06	0.000119	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PPARG—psoriasis	6.11e-06	0.000117	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PPARG—psoriasis	5.97e-06	0.000114	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—APOE—psoriasis	5.94e-06	0.000114	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PPARG—psoriasis	5.64e-06	0.000108	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CAT—psoriasis	5.32e-06	0.000102	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—APOE—psoriasis	5.18e-06	9.91e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PPARG—psoriasis	5.17e-06	9.91e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—APOE—psoriasis	4.88e-06	9.34e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—APOE—psoriasis	4.84e-06	9.26e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PPARG—psoriasis	4.51e-06	8.63e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PPARG—psoriasis	4.25e-06	8.13e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PPARG—psoriasis	4.21e-06	8.06e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—APOE—psoriasis	4.13e-06	7.91e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CAT—psoriasis	4.1e-06	7.86e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PPARG—psoriasis	3.6e-06	6.89e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—APOE—psoriasis	3.19e-06	6.1e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PPARG—psoriasis	2.78e-06	5.32e-05	CbGpPWpGaD
